HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MnTMPyP, a cell-permeant SOD mimetic, reduces oxidative stress and apoptosis following renal ischemia-reperfusion.

Abstract
Oxidative stress and apoptosis are important factors in the etiology of renal ischemia-reperfusion (I/R) injury. The present study tested the hypothesis that the cell-permeant SOD mimetic manganese(III) tetrakis(1-methyl-4-pyridyl)porphyrin (MnTMPyP) protects the kidney from I/R-mediated oxidative stress and apoptosis in vivo. Male Sprague-Dawley rats (175-220 g) underwent renal I/R by bilateral clamping of the renal arteries for 45 min followed by reperfusion for 24 h. To examine the role of reactive oxygen species (ROS) in renal I/R injury, a subset of animals were treated with either saline vehicle (I/R Veh) or MnTMPyP (I/R Mn) (5 mg/kg ip) 30 min before and 6 h after surgery. MnTMPyP significantly attenuated the I/R-mediated increase in serum creatinine levels and decreased tubular epithelial cell damage following I/R. MnTMPyP also decreased TNF-alpha levels, gp(91phox), and lipid peroxidation after I/R. Furthermore, MnTMPyP inhibited the I/R-mediated increase in apoptosis and caspase-3 activation. Interestingly, although MnTMPyP did not increase expression of the antiapoptotic protein Bcl-2, it decreased the expression of the proapoptotic genes Bax and FasL. These results suggest that MnTMPyP is effective in reducing apoptosis associated with renal I/R injury and that multiple signaling mechanisms are involved in ROS-mediated cell death following renal I/R injury.
AuthorsHuan Ling Liang, Gail Hilton, Jordan Mortensen, Kevin Regner, Christopher P Johnson, Vani Nilakantan
JournalAmerican journal of physiology. Renal physiology (Am J Physiol Renal Physiol) Vol. 296 Issue 2 Pg. F266-76 (Feb 2009) ISSN: 1931-857X [Print] United States
PMID19091787 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antioxidants
  • Metalloporphyrins
  • Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin
  • Tumor Necrosis Factor-alpha
  • Superoxides
  • 3-nitrotyrosine
  • Tyrosine
  • Creatinine
  • Superoxide Dismutase
  • Caspase 3
Topics
  • Animals
  • Antioxidants (metabolism)
  • Apoptosis (drug effects)
  • Caspase 3 (metabolism)
  • Creatinine (blood)
  • Gene Expression (drug effects)
  • Kidney (pathology)
  • Kidney Diseases (pathology, prevention & control)
  • Kidney Function Tests
  • Lipid Peroxidation (drug effects)
  • Male
  • Metalloporphyrins (pharmacology, therapeutic use)
  • Oxidative Stress (drug effects)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (metabolism, pathology, prevention & control)
  • Superoxide Dismutase (metabolism)
  • Superoxides (metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)
  • Tyrosine (analogs & derivatives, biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: